BARTOLETTI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 1.742
AS - Asia 754
EU - Europa 473
SA - Sud America 118
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.110
Nazione #
US - Stati Uniti d'America 1.710
SG - Singapore 368
CN - Cina 168
BR - Brasile 98
IT - Italia 81
HK - Hong Kong 78
RU - Federazione Russa 78
DE - Germania 77
VN - Vietnam 56
UA - Ucraina 43
GB - Regno Unito 40
SE - Svezia 29
IE - Irlanda 28
IN - India 27
FI - Finlandia 26
CA - Canada 17
BE - Belgio 15
FR - Francia 12
EG - Egitto 11
ES - Italia 11
MX - Messico 10
PL - Polonia 10
TR - Turchia 10
AR - Argentina 8
JP - Giappone 7
KR - Corea 7
BD - Bangladesh 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
ID - Indonesia 5
NL - Olanda 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
LT - Lituania 4
IQ - Iraq 3
VE - Venezuela 3
AZ - Azerbaigian 2
CO - Colombia 2
IR - Iran 2
PK - Pakistan 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 3.110
Città #
Ashburn 209
Chandler 193
Singapore 171
Fairfield 132
Woodbridge 110
Ann Arbor 91
Beijing 90
Hong Kong 78
Houston 65
Seattle 63
Wilmington 51
Boardman 44
Cambridge 44
New York 44
Los Angeles 32
Munich 30
Princeton 27
Dublin 26
Dearborn 23
Dong Ket 19
Jacksonville 18
Ho Chi Minh City 17
Redmond 16
Dallas 15
São Paulo 15
Brussels 14
Buffalo 14
Redondo Beach 12
Frankfurt am Main 11
Nuremberg 11
Turku 11
Poplar 10
Izmir 9
London 9
Martignacco 9
Montreal 9
San Diego 9
Stockholm 9
Warsaw 9
Chicago 8
Hefei 8
Helsinki 8
Ogden 8
Santa Clara 8
Denver 7
Des Moines 7
Tokyo 7
Chennai 6
Hyderabad 6
Seoul 6
Washington 6
Augusta 5
Belo Horizonte 5
Boston 5
Brooklyn 5
City of London 5
Düsseldorf 5
Johannesburg 5
San Francisco 5
Shanghai 5
Toronto 5
Andover 4
Brno 4
Falls Church 4
Hanoi 4
Leawood 4
Newark 4
Phoenix 4
San Mateo 4
Udine 4
Zoppola 4
Al Qahirah al Jadidah 3
Belluno 3
Bắc Ninh 3
Jinan 3
Majano 3
Miami 3
Milan 3
Nanjing 3
Orem 3
Portsmouth 3
Querétaro 3
Scafati 3
Secaucus 3
Abu Dhabi 2
Ardabil 2
Bagé 2
Baku 2
Benito Juarez 2
Bento Gonçalves 2
Brasília 2
Cairo 2
Calcinate 2
Chaozhou 2
Charlotte 2
Clifton 2
Coro 2
Dhaka 2
Dubai 2
Edinburgh 2
Totale 2.015
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 191
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 180
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 179
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 152
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 146
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 144
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study 139
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 128
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 123
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 121
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 113
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 109
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 100
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 94
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 92
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 86
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 81
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer 79
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: The virtual experience of the MITO cooperative group 71
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 70
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 69
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva 67
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 67
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 66
Managing COVID-19 in the oncology clinic and avoiding the distraction effect 65
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: A retrospective MITO group study 65
The Role of Obesity in Early and Long-Term Outcomes after Surgical Excision of Lung Oligometastases from Colorectal Cancer 61
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 58
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer 55
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 54
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 53
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization 51
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2NS) for Ovarian Cancer Therapy 41
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer 40
Late peritoneal carcinomatosis from cutaneous melanoma mimicking ovarian cancer 12
Totale 3.222
Categoria #
all - tutte 14.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021190 0 0 0 0 0 19 14 40 18 22 36 41
2021/2022256 20 17 6 7 9 7 16 8 1 38 95 32
2022/2023381 32 42 9 50 42 83 1 37 61 3 11 10
2023/2024187 19 16 15 9 31 44 0 10 12 9 0 22
2024/2025723 31 41 28 42 46 31 66 46 76 69 93 154
2025/2026836 201 123 91 143 261 17 0 0 0 0 0 0
Totale 3.222